Skip to Main Content

Scheduled Maintenance: CDAS will be undergoing maintenance on Saturday, February 7^th from 7:30 AM to 9:30 AM U.S. Eastern Standard Time for updates to the website. During this time you may experience intermittent downtime.

Browse Lab Results > 2005-0015

View 0 Studies Requested

Trial Summary

About CDAS Project, PI, Publications: Serum Levels of Cytokines, Other Immunologic Markers and non-Hodgkin Lymphoma: A Nested Case-Control Study in the PLCO Trial

Datasets

2005-0015 Primary

Site: Lymphoid

Inclusion Criteria:

No Baseline Cancer
Has T0 DNA or Serum
Not Prevalent Cancer

Matching Factors:

Age at Randomization (5 year intervals)
Race
Gender
Study Center
Season of Blood Draw
Time of Blood Draw (am/pm)
Study Year of Exit

Match Ratio: 1 to 1

Match Technique: Frequency matching with replacement and cases as controls (Incidence Density)

Analytes:

C-Reactive Protein
Interleukin 10
Interleukin 4
Interleukin 6
Soluble Tumor Necrosis Factor Receptor I
Soluble Tumor Necrosis Factor Receptor II
Tumor Necrosis Factor Alpha
Tumor Necrosis Factor Receptor Superfamily, Member 7
Tumor Necrosis Factor Receptor Superfamily, Member 8

Number of Cases: 297

Number of Controls: 297

Site: Lymphoid

Inclusion Criteria:

No Baseline Cancer
Has T0 DNA or Serum
Not Prevalent Cancer

Matching Factors:

Age at Randomization (5 year intervals)
Race
Gender
Study Center
Season of Blood Draw
Time of Blood Draw (am/pm)
Study Year of Exit

Match Ratio: 1 to 1

Match Technique: Frequency matching with replacement and cases as controls (Incidence Density)

Analytes:

C-Reactive Protein
Interleukin 10
Interleukin 4
Interleukin 6
Soluble Tumor Necrosis Factor Receptor I
Soluble Tumor Necrosis Factor Receptor II
Tumor Necrosis Factor Alpha
Tumor Necrosis Factor Receptor Superfamily, Member 7
Tumor Necrosis Factor Receptor Superfamily, Member 8

Number of Cases: 297

Number of Controls: 297